Matinas BioPharma Holdings, Inc. (MTNB) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $859.0K2014: $1.13M2015: $2.33M2016: $2.67M2017: $3.74M2018: $3.80M2019: $7.19M2020: $7.24M2021: $8.83M2022: $8.18M2023: $5.86M2024: $5.05M2025: $2.38M$2.38M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$2.38M-52.9%
2024$5.05M-13.8%
2023$5.86M-28.4%
2022$8.18M-7.4%
2021$8.83M+22.0%
2020$7.24M+0.7%
2019$7.19M+89.1%
2018$3.80M+1.6%
2017$3.74M+40.3%
2016$2.67M+14.3%
2015$2.33M+105.9%
2014$1.13M+32.0%
2013$859.0K